MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-18-0005844
JMB Pharmaceuticals Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹25.18 Cr
▲ 22% YoY
Net profit · FY 2024
₹1.27 Cr
Net margin 5%
EBITDA · FY 2024
₹2.04 Cr
EBITDA margin 8.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹85 Lakh
Issued & subscribed
Open charges
₹4.39 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
About JMB Pharmaceuticals Private Limited
Data last updated:
JMB Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 28 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U32503MH2014PTC256657. Its GSTIN is 27AADCJ3908N1Z8 (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹85 Lakh. It is led by directors John Benno Marina and Benno John Nangani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 17 Meghal Industrial Estate Devidayal Road Mulund (W), Mumbai, Maharashtra, India – 400080.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.18 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹1.27 Cr (net margin 5%) and EBITDA of ₹2.04 Cr (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 13% over five years.
The company is associated with 1 brand: JMB Pharmaceuticals. As per MCA filings, the company has open charges of ₹4.39 Cr on record.
JMB Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0005844). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jmbpharma.com.
Company details
CIN U32503MH2014PTC256657
Registration Number 256657
Incorporation Date 28 July 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0005844
CIN history
JMB Pharmaceuticals has one previous CIN (Corporate Identification Number): U24233MH2014PTC256657. The current CIN is U32503MH2014PTC256657, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U32503MH2014PTC256657 | Current |
| U24233MH2014PTC256657 | Previous |
Recognitions & Rankings of JMB Pharmaceuticals
Contact details
JMB Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is jmbpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressG – 17 Meghal Industrial Estate Devidayal Road Mulund (W), Mumbai, Maharashtra, India – 400080
- IndustryHealthcare, Medical & Laboratory Equipment, Medical Consumables & Supplies
To see the full contact details of JMB Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
JMB Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
JMB Pharmaceuticals operates one associated brand: JMB Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations and veterinary products manufacturing in Mumbai. | jmbpharma.com |
Business activity
The main business activity of JMB Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of JMB Pharmaceuticals Private Limited, buy the company report.
Financials of JMB Pharmaceuticals Private Limited
FY 2025 filings availableJMB Pharmaceuticals Private Limited reported revenue of ₹25.18 Cr (up 22% YoY) for FY 2024.
Revenue · FY 2024
₹25.18 Cr ▲ 22%
Net profit · FY 2024
₹1.27 Cr margin 5%
EBITDA · FY 2024
₹2.04 Cr margin 8.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 22%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 14%
5 years · compounded
▲ 6%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 22% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.04 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.27 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.1% | ||||
| Net Profit Margin | 5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of JMB Pharmaceuticals Private Limited, buy the company report.
Board of directors of JMB Pharmaceuticals Private Limited
JMB Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| John Benno Marina | Director | 30 Nov 2021 | 4 Years 10 Months | Current |
| Benno John Nangani | Director | 28 Jul 2014 | 12 Years 2 Months | Current |
Peer comparison
JMB Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Formulations, Medical Consumables, Medical and Laboratory Equipment), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| JMB Pharmaceuticals Private Limitedthis company | ₹25.18 Cr (FY 2024) | ₹1.27 Cr | 5% | 22.0% | Mumbai, Maharashtra, India | |
| Fitwel Pharmaceuticals Private Limited | ₹25.09 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India | |||
| Unistar Biotech Limited | ₹25.06 Cr (FY 2025) | 57.0% | Ahmedabad, Gujarat, India | |||
| Genuine Biosystem Private Limited | ₹25.06 Cr (FY 2024) | 26.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of JMB Pharmaceuticals Private Limited, buy the company report.
Auditor
JMB Pharmaceuticals Private Limited is audited by V. VAIDYANATHAN & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V. VAIDYANATHAN & CO. | FY 2022 | 111225W |
Shareholding
The shareholding of JMB Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of JMB Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.39 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Apr 2025 | 101095547 | Hdfc Bank Limited | ₹38 Lakh | Open | |
| 01 Jun 2020 | 100340063 | Others | ₹20 Lakh | Open | |
| 01 Jun 2020 | 100340064 | Others | ₹21 Lakh | Open | |
| 16 May 2016 | 100035643 | Others | ₹10 Lakh | Open | |
| 30 Jun 2015 | 10581914 | Others | ₹3.5 Cr | Open |
To see the full charge records of JMB Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving JMB Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for JMB Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
JMB Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCJ3908N1Z8 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of JMB Pharmaceuticals Private Limited, buy the company report.
Recent activity
JMB Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Benny John Nangani ceased to be Director on 24 Jan 2022.
AGM
Jmb Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.38 Cr with Charge ID 101095547 was registered on 05 Apr 2025.
Filing
Jmb Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others of Rs. 3.50 Cr registered on 30 Jun 2015 with Charge ID 10581914 was modified on 17 Feb 2024.
Ceased
Benny John Nangani ceased to be Director.
Appointed
John Benno Marina was appointed as Director.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100340063 was registered on 01 Jun 2020.
Charges
A charge with Others amounted to Rs. 0.21 Cr with Charge ID 100340064 was registered on 01 Jun 2020.
Charges
A charge with Others amounted to Rs. 0.10 Cr with Charge ID 100035643 was registered on 16 May 2016.
Charges
A charge with Others amounted to Rs. 3.50 Cr with Charge ID 10581914 was registered on 30 Jun 2015.
Appointed
Benno John Nangani was appointed as Director.
Incorporation
28 Jul 2014
Jmb Pharmaceuticals Private Limited was registered on 28 Jul 2014 with Roc Mumbai & aged 12 years 2 months as per MCA records.
Frequently asked questions
JMB Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 28 July 2014 (12+ years old) and is registered under CIN U32503MH2014PTC256657.
JMB Pharmaceuticals has 2 current directors:
- John Benno Marina - Director
- Benno John Nangani - Director
The latest financial statements of JMB Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of JMB Pharmaceuticals is 27AADCJ3908N1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of JMB Pharmaceuticals is U32503MH2014PTC256657. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
JMB Pharmaceuticals was incorporated on 28 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of JMB Pharmaceuticals by revenue are Fitwel Pharmaceuticals Private Limited, Unistar Biotech Limited, Genuine Biosystem Private Limited, all in the Healthcare industry (Formulations, Medical Consumables, Medical and Laboratory Equipment), with the same principal business activity (wholesale trading).
Benny John Nangani ceased to be Director on 24 Jan 2022. John Benno Marina was appointed as Director on 30 Nov 2021. Benno John Nangani was appointed as Director on 28 Jul 2014.
Yes, JMB Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0005844).
JMB Pharmaceuticals can be reached through the website jmbpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of JMB Pharmaceuticals is at G – 17 Meghal Industrial Estate Devidayal Road Mulund W, Mumbai, Maharashtra, India – 400080.